1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer : A Nationwide Population-based Study
(
- Contribution to journal › Article
-
Mark
Confirmatory Biopsy Outcomes in Patients with Grade Group 2 Prostate Cancer : Implications for Early Management
(
- Contribution to journal › Article
-
Mark
Prognostic Testing for Prostate Cancer—A Cost-Effectiveness Analysis Comparing a Prostatype P-Score Biomarker Approach to Standard Clinical Practice
2025) In PharmacoEconomics(
- Contribution to journal › Article
-
Mark
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma
(
- Contribution to journal › Article
-
Mark
Validation of a Swedish version of the National Institute of Health - Chronic Prostatitis Symptom Index
(
- Contribution to journal › Article
-
Mark
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer : A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels
(
- Contribution to journal › Article
-
Mark
SGLT2 Inhibitors in Patients with Urogenital Malformations and Urinary Diversions : Risks, Benefits, and Clinical Considerations
(
- Contribution to journal › Scientific review
-
Mark
Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti's Letter to the Editor re : Andreas Josefsson, Marianne Månsson, Kimia Kohestani, et al. Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial. Eur Urol 2024;86:223-9
(
- Contribution to journal › Article
- 2018
-
Mark
Port-site Metastases After Robot-assisted Radical Cystectomy : Is There a Publication Bias?
(
- Contribution to journal › Letter